Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
Abstract Aims Identification of patients with type 2 diabetes (T2D) at increased risk of incident heart failure (HF) beyond traditional risk factors such as prior myocardial infarction (MI) might allow selection of patients who would benefit from preventative treatment. Microvascular disease (MiVD)...
Saved in:
| Main Authors: | Ify R. Mordi, Aaron Tee, Colin N. Palmer, Rory J. McCrimmon, Alexander S.F. Doney, Chim C. Lang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-06-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.12669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart failure with preserved ejection fraction: the role of microvascular dysfunction
by: K. V. Kopeva, et al.
Published: (2023-01-01) -
Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes
by: Mohammad Ghouse Syed, et al.
Published: (2025-01-01) -
Fluoroscopic methods of assessment of coronary microvascular dysfunction – a review of literature
by: R. Grigorov, et al.
Published: (2025-05-01) -
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction
by: Sanne G. J. Mourmans, et al.
Published: (2025-04-01) -
Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis
by: Joanna M Bilak, et al.
Published: (2022-07-01)